Association of AGER gene G82S polymorphism with the severity of coronary artery disease in Chinese Han population

Clinical Endocrinology

Volumn 75, Issue 4, 2011, Pages 470-474

  Lu, Weixin ^a   Feng, Bo ^b   Xie, Guangping ^a   Liu, Fengjing ^b  

^a HUZHOU UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHINESE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC;

EID: 80052552078     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04079.x     Document Type: Article

References (27)

1. Neeper, M., Schmidt, A.M., Brett, J., et al. (1992) Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. Journal of Biological Chemistry, 267, 14998-15004.
2. Schmidt, A.M., Vianna, M., Gerlach, M., et al. (1992) Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. Journal of Biological Chemistry, 267, 14987-14997.
3. Basta, G., (2008) Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications. Atherosclerosis, 196, 9-21.
4. Kalea, A.Z., Schmidt, A.M., &, Hudson, B.I., (2009) RAGE: a novel biological and genetic marker for vascular disease. Clinical Science (Lond), 116, 621-637.
5. Hofmann, M.A., Drury, S., Fu, C., et al. (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell, 97, 889-901. (Pubitemid 29375048)
6. Hori, O., Brett, J., Slattery, T., et al. (1995) The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. Journal of Biological Chemistry, 270, 25752-25761.
7. Schmidt, A.M., Yan, S.D., Yan, S.F., et al. (2001) The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. Journal of Clinical Investigation, 108, 949-955. (Pubitemid 32946067)
8. Chavakis, T., Bierhaus, A., Al-Fakhri, N., et al. (2003) The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. Journal of Experimental Medicine, 198, 1507-1515. (Pubitemid 37467165)
9. Park, L., Raman, K.G., Lee, K.J., et al. (1998) Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nature Medicine, 4, 1025-1031. (Pubitemid 28417334)
10. Bucciarelli, L.G., Wendt, T., Qu, W., et al. (2002) RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation, 106, 2827-2835. (Pubitemid 35396983)
11. Wendt, T., Harja, E., Bucciarelli, L., et al. (2006) RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes. Atherosclerosis, 185, 70-77. (Pubitemid 43117552)
12. Sugaya, K., Fukagawa, T., Matsumoto, K., et al. (1994) Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3. Genomics, 23, 408-419. (Pubitemid 24308262)
13. Hudson, B.I., Stickland, M.H., &, Grant, P.J., (1998) Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups. Diabetes, 47, 1155-1157. (Pubitemid 28294561)
14. Pulkkinen, A., Viitanen, L., Kareinen, A., et al. (2000) Gly82Ser polymorphism of the receptor of advanced glycation end product gene is not associated with coronary heart disease in Finnish nondiabetic subjects or in patients with type 2 diabetes. Diabetes Care, 23, 864. (Pubitemid 30414213)
15. Pettersson, F.K., Forsblom, C., Hudson, B.I., et al. (2003) The functional -374T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients. Diabetes, 52, 891-894. (Pubitemid 36323601)
16. Hofmann, M.A., Yang, Q., Harja, E., et al. (2005) The RAGE Gly82Ser polymorphism is not associated with cardiovascular disease in the Framingham offspring study. Atherosclerosis, 182, 301-305. (Pubitemid 41267198)
17. Yoon, S.J., Park, S., Shim, C.Y., et al. (2007) Association of RAGE gene polymorphisms with coronary artery disease in the Korean population. Coronary Artery Disease, 18, 1-8. (Pubitemid 44973749)
18. Lu, L., Jin Pu, L., Chen, Q.J., et al. (2008) Increased glycated albumin and decreased esRAGE concentrations are associated with in-stent restenosis in Chinese diabetic patients. Clinica Chimica Acta, 396, 33-37.
19. Peng, W.H., Lu, L., Wang, L.J., et al. (2009) RAGE gene polymorphisms are associated with circulating levels of endogenous secretory RAGE but not with coronary artery disease in Chinese patients with type 2 diabetes mellitus. Archives of Medical Research, 40, 393-398.
20. Gao, J.X., Shao, Y.H., Lai, W.Y., et al. (2010) Association of polymorphisms in the RAGE gene with serum CRP levels and coronary artery disease in the Chinese Han population. Journal of Human Genetics, 55, 668-675.
21. World Health Organization-Western Pacific Region (2000) International association for the study of obesity and the international obesity taskforce. Perspective: Redefining Obesity and its Treatment. February, 2000.
22. World Health Organization-International Society of Hypertension (1999) Guidelines for the management of hypertension. Guidelines subcommittee. Journal of Hypertension, 17, 151-183.
23. Third Report of the National Cholesterol Education Program (NCEP) (2002) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation, 106, 3143-3421.
24. Miwa, K., Nakagawa, K., Yoshida, N., et al. (2000) Lipoprotein(a) is a risk factor for occurrence of acute myocardial infarction in patients with coronary vasospasm. Journal of the American College of Cardiology, 35, 1200-1205. (Pubitemid 30206895)
25. Ringqvist, I., Fisher, L.D., Mock, M., et al. (1983) Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). Journal of Clinical Investigation, 71, 1854-1866. (Pubitemid 13056789)
26. Gensini, G.G., (1983) A more meaningful scoring system for determining the severity of coronary heart disease. American Journal of Cardiology, 51, 606. (Pubitemid 13187192)
27. Hofmann, M.A., Drury, S., Hudson, B.I., et al. (2002) RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes and Immunity, 3, 123-135. (Pubitemid 38961122)